ASMLs, Report

ASML's Q1 Report to Test Rally Amid Regulatory and Geopolitical Crosswinds

11.04.2026 - 07:43:26 | boerse-global.de

ASML's Q1 results, due April 15, will test its ability to convert a €38.8B backlog into revenue amid new US export control threats and volatile geopolitics impacting its key Asian market.

ASML's Q1 Report to Test Rally Amid Regulatory and Geopolitical Crosswinds - Foto: über boerse-global.de

ASML Holding NV's upcoming quarterly results will serve as a critical gauge for its recent stock performance, which has been buffeted by fleeting geopolitical optimism and looming regulatory threats. The Dutch chip equipment maker is set to report first-quarter figures on Tuesday, April 15, against a backdrop where a 25% share price gain since the start of the year meets persistent uncertainty.

Investor focus will be squarely on the company's ability to convert its massive order backlog into revenue. The order book stands at €38.8 billion, and the efficiency of this conversion is a key metric for analysts. Consensus estimates point to quarterly revenue of approximately $9.99 billion, with earnings per share expected around $7.67. ASML's own guidance for the period projects sales between €8.2 and €8.9 billion, with a gross margin of 51% to 53%. This represents a noticeable decline from the 54% margin reported a year ago, attributed to product mix and weaker service revenue.

The report will also be scrutinized for any update on the full-year outlook. The company has maintained a 2026 revenue forecast of €34 to €39 billion, and confirmation of this range is a primary concern for the market. Management, including CEO Christophe Fouquet and CFO Roger Dassen, will host an investor call at 15:00 CET on Tuesday to elaborate on the figures.

Geopolitical events provided a volatile prelude to the earnings release. News of a two-week ceasefire between the US and Iran sparked a broad market rally mid-week, lifting ASML's shares by roughly nine percent. The relief was particularly acute for the firm, as Asia typically accounts for 60% to 70% of its annual sales, and a prolonged closure of the Strait of Hormus would have severely impacted regional economies. However, the optimism proved short-lived. Iran re-closed the vital waterway following Israeli strikes in Lebanon, causing oil prices to rise and markets to reverse gains.

Should investors sell immediately? Or is it worth buying Asml?

Simultaneously, a new legislative risk emerged from Washington. A bipartisan group of US lawmakers, led by Representative Michael Baumgartner, introduced the MATCH Act. The proposed legislation seeks to extend export controls to older deep ultraviolet (DUV) lithography machines—precisely the equipment Chinese chipmakers are still permitted to buy. Analyst Ben Barringer of Quilter Cheviot quantified the potential impact, noting these older systems represent 10% to 15% of total sales, with about half of that stemming from China. This translates to a revenue risk of approximately five percent, though the effect would likely diminish over time.

This regulatory pressure amplifies existing questions about ASML's exposure to China. The company previously projected that China's share of sales would normalize to around 20% in 2026, down from an estimated 33% in 2025. This forecast did not account for the potential MATCH Act. Offsetting this risk is robust demand for the company's most advanced systems. Revenue from extreme ultraviolet (EUV) machines grew 39% in 2025, and over half of new bookings are for EUV tools. Shipments of the next-generation High-NA EUV system, the TWINSCAN EXE:5200B, are progressing, with Intel completing acceptance tests and SK Hynix having already installed one in a DRAM fab. Mass production is anticipated for 2027 and 2028.

Ahead of the earnings, analyst sentiment has been bolstering the stock. TD Cowen raised its price target to €1,600 from €1,500, reiterating a buy rating. Bank of America Securities increased its target to €1,598 and lifted its sales and profit estimates for 2026 through 2028. The average analyst price target sits around €1,482, suggesting an 18% upside from recent levels.

Asml at a turning point? This analysis reveals what investors need to know now.

The week following the quarterly report brings other key events. The annual general meeting in Veldhoven on April 22 will see shareholders vote on the appointment of Marco Pieters as the new Chief Technology Officer and the reappointment of CFO Roger Dassen for a four-year term. The ex-dividend date for a final dividend of €2.70 per share is set for April 24, marking a 17% increase from the 2024 payout.

Looking further ahead, ASML's long-term targets remain unchanged, with the company aiming for annual revenue of €44 to €60 billion by 2030 and gross margins between 56% and 60%. The immediate task, however, is navigating the dual challenges of converting a record backlog and managing geopolitical and regulatory headwinds, starting with Tuesday's financial disclosure.

Ad

Asml Stock: New Analysis - 11 April

Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Asml analysis...

So schätzen die Börsenprofis ASMLs Aktien ein!

<b>So schätzen die Börsenprofis ASMLs Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | NL0010273215 | ASMLS | boerse | 69122906 |